Blog

Articles, guides, and regulatory updates from our community.

AllClinical ApplicationsLongevityPeptide BasicsProvider ResourcesResearch & ScienceSafety & RegulationWeight Management
503A503BAnti-AgingBPC-157BremelanotideCJC-1295CircadianComplianceCompoundingCopper PeptideDSIPEpitalonEvidence ReviewFDAFDA ApprovedGHK-CuGIGLP-1Getting StartedGrowth HormoneGut HealthHealingHumaninIBSImmune SupportImmunologyIpamorelinKPVLarazotideLongevityMOTS-cMelanocortinMitochondriaNAD+ObesityPT-141Patient EducationPeptide BasicsPharmacyProvider GuideQualityRecoveryRegulationResearchSafetySemaglutideSexual HealthSide EffectsSkin HealthSleepTesamorelinThymosin Alpha-1TirzepatideWeight Management
Showing 1 article tagged FDAClear filters
Feb 25, 202610 min read
Safety & Regulation

FDA Peptide Regulation in 2026: What Providers Need to Know

The regulatory landscape for compounded peptides has shifted dramatically. Here's what clinicians must understand about FDA enforcement, 503A/503B rules, and the bulk drug substance list.

FDARegulationCompounding+3

By Peptide Association Editorial Team